Laser therapy for neurological conditions - the evidence
What the research really says about low-level laser therapy (photobiomodulation) and transcranial laser therapy for neurological conditions.
Low-level laser (photobiomodulation) applied to the brain is biologically plausible and shows promise in animal models and small trials, but large randomised controlled trials have not yet confirmed clinical benefit. It should be regarded as experimental.
Two distinct uses
It is important to distinguish between two different applications:
| Type | What it is | Evidence status |
|---|---|---|
| Transcranial laser (NILT/PBM) | Near-infrared light applied to the skull to penetrate brain tissue | Experimental - failed in a large stroke trial |
| Low-level laser therapy (LLLT) | Applied to joints or muscles for pain and inflammation | Mixed for pain; separate from neurological use |
Transcranial laser for acute stroke: a cautionary trial
Hamblin’s review of photobiomodulation for brain disorders outlined the theoretical rationale: near-infrared wavelengths (810 nm) can penetrate scalp and skull, reach cortical tissue, and in animal models stimulate mitochondrial function, reduce inflammation, and improve neurological outcomes after injury [Hamblin MR 2016] .
However, the NEST-3 trial - a phase III randomised, sham-controlled trial of transcranial laser therapy in acute ischaemic stroke - found no significant improvement in the primary outcome (neurological function at 90 days) in 566 patients [Hacke W 2014] . Subgroup analyses suggested possible benefit in less severe strokes, but these are hypothesis-generating, not confirmatory.
Photobiomodulation for TBI and other conditions
Smaller trials and case series suggest photobiomodulation may improve cognitive function and mood after chronic TBI, and reduce neuroinflammation. These remain promising preliminary findings. Without blinded randomised controlled trials of adequate size, clinical recommendations cannot be made.
What this means for patients
| Question | Honest answer |
|---|---|
| Is it safe? | Low-level laser appears safe at approved parameters |
| Does it work for stroke recovery? | Not confirmed; the best-designed trial was negative |
| Should I try it? | Discuss with your neurologist; don’t substitute it for evidence-based therapy |
| Is it covered by healthcare? | Rarely; it is generally out-of-pocket |
Putting it in context
Laser therapy sits alongside other emerging interventions where the science is interesting, the evidence is preliminary, and the clinical translation is still being worked out. The enthusiasm of proponents and the stories of individuals who report benefit don’t substitute for large, controlled evidence - but neither should they be dismissed without further rigorous investigation.
The honest position: experimental - watch this space, but don’t reorganise your rehab around it yet.
Helpful next
References (2)
- 1. Hamblin MR (2016). Shining light on the head: photobiomodulation for brain disorders. BBA Clinical, 6, 113-124. doi:10.1016/j.bbacli.2016.09.002
- 2. Hacke W, Schellinger PD, Albers GW, et al. (2014). Transcranial laser therapy in acute stroke treatment: results of Neurothera Effectiveness and Safety Trial 3 (NEST-3), a phase III clinical trial. Stroke, 45(11), 3187-3193. doi:10.1161/STROKEAHA.114.005795